Major players in the veterinary antibiotics market are Bayer AG, Boehringer Ingelheim GmbH, Ceva Santé Animale, Eli Lilly Company, Elanco, Merck & Co, Sanofi, Virbac, Zoetis, and Crystal Pharma.
New York, May 26, 2022 (GLOBE NEWSWIRE) — Reportlinker.com Announces Release of “Veterinary Antibiotics Global Market Report 2022” – https://www.reportlinker.com/p06281027/?utm_source=GNW
The global veterinary antibiotics market is expected to grow from $0.28 billion in 2021 to $0.31 billion in 2022 at a compound annual growth rate (CAGR) of 8.1%. The market is expected to reach $0.39 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%.
The veterinary antibiotics market consists of the sale of veterinary antibiotics and related services. Veterinary antibiotics are used to fight infections and diseases in animals caused by bacteria.
The veterinary antibiotics industry includes companies involved in the production of antibiotics used for the therapeutic and prophylactic treatment of animals.
The main types of veterinary antibiotic products include antiparasitics, antibacterials, nonsteroidal anti-inflammatory drugs and other products. Nonsteroidal anti-inflammatory drugs (NSAIDs) act as a bridge between the production and activity of prostaglandins (enzymes) involved in inflammation.
Veterinary approved NSAIDs are used in pet care to reduce pain and swelling associated with osteoarthritis in dogs and horses. Administration of veterinary antibiotics includes premixes, injections, oral powders, oral solutions, and other administrations used on farm animals and pets.
North America was the largest region in the veterinary antibiotics market in 2021. Asia-Pacific was the second largest region in the veterinary antibiotics market. Regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
An increase in the number of zoonotic diseases is driving the veterinary antibiotics market. Zoonotic diseases are infectious diseases caused by microscopic organisms, infections, and parasites that spread between animals and humans.
Two of the most common zoonotic pathogens, salmonella and campylobacter, are present in the intestines of these animals. Zoonotic diseases also pose a potential threat to humans as they are transferred through the food chain.
A study conducted by the FoodNet (Centers for Disease Control and Prevention, USA) revealed that 24,484 foodborne illnesses, 5,677 hospitalizations and 122 deaths are due to zoonotic diseases. Additionally, the highest incidences per 100,000 population in the United States are due to infectious diseases such as campylobacter, salmonella, and shigella.
Hence, there is a need to diagnose these diseases in animals at an early stage, which is a major driver of the veterinary antibiotics market.
The growing threat of antibiotic resistance is a major constraint for the veterinary antibiotics market. Antibiotic resistance in animals is the ability of a microbe to resist the impact of an antibiotic that once could successfully treat the infection of the same type of microbe.
This may be the result of using antibiotics above the prescribed limit. In this regard, the European Union (EU) has approved various restrictions on veterinary antibiotics, including banning antibiotics for animals and banning the use of antimicrobials in food, which limits the growth of the veterinary antibiotics market.
Increasing collaboration between companies is an emerging trend in the veterinary antibiotics market. The collaboration offers companies a combination of technologies and a broader, more diverse product portfolio to work with, and it also improves the quality of antibiotics and the speed at which they are produced.
Hence, companies in the veterinary antibiotics market are focusing on collaborations. For example, in April 2019, Bayer AG entered into a strategic collaboration with Adiva GmbH to develop therapeutic antibodies for veterinary medicine.
The prescription veterinary antibiotic market is regulated by Section 503(f) of the FDA Food, Drug and Cosmetic Act. According to this law, the labels of veterinary antibiotics must include a warning indicating that these drugs can only be used with the permission of a licensed veterinarian.
The sale and use of prescription antibiotics without a prescription is usually reported to the FDA and strict action is taken accordingly. Therefore, regulations such as these would regulate the manufacturers and sellers of veterinary antibiotics.
Countries covered in the Veterinary Antibiotics market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK and the United States.
Read the full report: https://www.reportlinker.com/p06281027/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001